Source: Virtual Congress 2020 – Air pollution and comorbidities
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. Rodrigues Sousa (Coimbra, Portugal), J. Nunes Caldeira (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal), A. Figueiredo (Coimbra, Portugal), F. Barata (Coimbra, Portugal). Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease. 131

Member's Comments

No comment yet.

Related content which might interest you: Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 2014 Year: 2014 Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 1999 Year: 1999 Patterns of Oxygen Pulse Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Nutritional Supplementation during Pulmonary Rehabilitation in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases Year: 2019 Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Chronic Obstructive Pulmonary Disease: A Forgotten Killer Source: Eur Respir J 2009; 33: 456 Year: 2009 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 The Use of Respiratory Sounds for Automated Detection of Obstructive Pulmonary Disease: Do Lung Sound Labels Provide Value? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Cardiac Involvement In Chronic Obstructive Pulmonary Disease (COPD) Secondary To Post TB Bronchiectasis V/S Non Post Tb Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019